Product Information
VERAPAMIL SR 180 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $1.1467 per EA under NDC 52536088201. Its NADAC has been published 73 times since Feb 5, 2025.
Strength
180 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536088201
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019614On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 180 MG CAPSULE has been published 73 times since Feb 5, 2025, and over the history we have for it it has risen 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1467 per EA |
|---|---|
| All-time high | $2.2961 (Mar 11, 2026) |
| All-time low | $0.9764 (Feb 19, 2025) |
| 52-week high | $2.2961 |
| 52-week low | $1.0263 |
| Median price | $1.2552 |
| Average price | $1.4302 |
| Largest weekly change | +27.4% (Sep 17, 2025) |
| Weeks tracked | 73 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 180 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $1.1467 per EA (NDC 52536088201), effective Jun 24, 2026.
How has the price of VERAPAMIL SR 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 180 MG CAPSULE has risen 12.3%. It has been tracked across 73 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 180 MG CAPSULE?
Since Feb 5, 2025, the NADAC for VERAPAMIL SR 180 MG CAPSULE has ranged from a low of $0.9764 (Feb 19, 2025) to a high of $2.2961 (Mar 11, 2026), with a median of $1.2552 per EA.
Are there cheaper alternatives to VERAPAMIL SR 180 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VERAPAMIL ER 180 MG TABLET, is $0.1930 per EA — about 83% below VERAPAMIL SR 180 MG CAPSULE.
Who manufactures VERAPAMIL SR 180 MG CAPSULE?
VERAPAMIL SR 180 MG CAPSULE (NDC 52536088201) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification